Bionomics Limited (BNO.AX)
| Previous close | 0.0460 |
| Open | 0.0450 |
| Bid | 0.0460 x 2640300 |
| Ask | 0.0480 x 16362900 |
| Day's range | 0.0450 - 0.0470 |
| 52-week range | 0.0440 - 0.2050 |
| Volume | |
| Avg. volume | 586,042 |
| Market cap | 63.607M |
| Beta (5Y monthly) | 2.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0170 |
| Earnings date | 23 Aug 2022 - 29 Aug 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Bionomics Limited to Participate in the H.C. Wainwright Mental Health Conference
ADELAIDE, Australia, June 27, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that Dr. Errol De Souza, Executive Chairman of Bionomics, will participate in a fireside chat at the First Annual H.C. Wainwright
- GlobeNewswire
Bionomics Investor Webinar
ADELAIDE, Australia, June 13, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (ASX: BNO |Nasdaq: BNOX ), (Bionomics or the Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, invites shareholders and interested parties to attend an investor webinar with Executive Chairman Dr. Errol De Souza and Vice President of St
- GlobeNewswire
Bionomics Limited to Participate in Upcoming Investor Conferences
ADELAIDE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced that Dr Errol De Souza, Executive Chairman of Bionomics, will participate in three upcoming investor conferences: Citibank Biotech’
